Search

everythinglearnresearchcommunity

for

Search:↓

Scalp cooling reduces chemotherapy-induced hair loss without increasing risk of skin metastases.

Lichen planus pigmentosus causes dark skin patches and is treated by avoiding triggers and using anti-inflammatory medications.

Mycophenolate mofetil was effective for most patients in treating scarring hair loss, but some had side effects.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Scalp microneedling may improve hair density and thickness for various alopecia types.

Low-dose oral minoxidil effectively treats non-scarring hair loss with some side effects like hypertrichosis and postural hypotension.

Azathioprine is the most continued treatment for chronic alopecia areata over a year, often with added low-dose prednisolone.

Platelet-Rich Plasma (PRP) can promote new hair growth and increase hair density, but its effectiveness varies depending on the type of hair loss.

PRP treatment may promote hair growth and improve hair density in women with AGA, but more research is needed.

Pregnancy can cause unique skin issues, some of which may risk the mother and baby's health and need careful treatment.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

Twins had rare skin cysts likely due to genetics.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

Ginger extract helps hair growth and reduces the need for prednisolone in alopecia areata patients.

Cortexolone 17a-propionate may be an effective new treatment for hair loss.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

Dermatoscopy and videodermatoscopy are useful for diagnosing and monitoring various skin, hair, and nail conditions.

Treatment with plasma rich in growth factors improved hair density and thickness for hair loss patients.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Dermatoscopy and videodermatoscopy are useful and reliable for tracking treatment progress in various skin conditions.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

Minoxidil effectively treats female pattern hair loss.

Menopause affects hair and skin; more research needed for treatment.

People with Lichen Planus, especially with mucosal involvement, are more likely to have Metabolic Syndrome, which increases their risk for heart disease and diabetes.

Platelet-rich plasma treatment for non-scarring hair loss shows mixed results and needs more research.

Most people with alopecia areata have nail changes, which are common but don't greatly affect their quality of life.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

Melanoma development can be linked to the breakdown of skin's melanin-producing units.